Mucinex Nightshift Sinus Tablet, Coated
NDC Package 72854-209-20
Package Information
Mucinex Nightshift Sinus (acetaminophen, dextromethorphan hydrobromide, and triprolidine hydrochloride) tablets is uses ■ temporarily relieves these common cold and flu symptoms: ■ cough ■ minor aches and pains ■ sore throat ■ headache ■ runny nose ■ sneezing ■ itching of the nose or throat ■ itchy, watery eyes due to hay fever ■ temporarily reduces fever ■ controls cough to help you get to sleep. This formulation utilizes a tablet, coated delivery system. Marketed by Rb Health (us) Llc, this product is identified by NDC 72854-209 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2549034 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / triprolidine HCl 1.25 MG Oral Tablet
- RxCUI: 2549034 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / triprolidine hydrochloride 1.25 MG Oral Tablet
- RxCUI: 2549034 - APAP 325 MG / dextromethorphan hydrobromide 10 MG / triprolidine hydrochloride 1.25 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72854 - Rb Health (us) Llc
- 72854-209 - Mucinex Nightshift Sinus
- 72854-209-20 - 2 BLISTER PACK in 1 CARTON / 10 TABLET, COATED in 1 BLISTER PACK
- 72854-209 - Mucinex Nightshift Sinus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72854-209-20 identifies a specific commercial package of 2 blister pack in 1 carton / 10 tablet, coated in 1 blister pack of Mucinex Nightshift Sinus Maximum Strength, a human over the counter drug labeled by Rb Health (us) Llc. This tablet, coated is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide; triprolidine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rb Health (us) Llc on May 01, 2025. The current certification is valid through December 31, 2026.
How is this Rb Health (us) Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72854020920. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.